Shanghai - Delayed Quote CNY

TALOPH PHARM (600222.SS)

5.36
-0.03
(-0.56%)
At close: 3:00:02 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Jingliang Li GM & Vice Chairman -- -- 1969
Mr. Hailin Zhao CFO & Executive Deputy GM -- -- 1975
Mr. Lizhuang Zhang Deputy General Manager -- -- 1966
Mr. Fengshan Su Deputy General Manager -- -- 1977
Ms. Nianyun Li Deputy GM & Secretary -- -- 1991

TALOPH PHARM

No. 8 Jinsuo Road
High-Tech Industrial Development Zone
Zhengzhou, 450001
China
86 37 1679 93688 https://www.taloph.com
Sector: 
Healthcare
Full Time Employees: 
2,214

Description

Henan Taloph Pharmaceutical Stock Co.,Ltd engages in the research, development, and sale of pharmaceutical preparations and Chinese herbal medicines in China. Its principal products include Shuanghuanglian oral liquid series, Shuangjinlian mixture, Danshen oral liquid, pediatric heat-clearing and cough-relieving oral liquid, pediatric compound chicken gizzard chewable tablets, and Huperzine A tablets. The company serves hospitals, primary medical institutions, and retail terminals. The company was formerly known as Henan Joyline & Joysun Pharmaceutical Stock Co., Ltd. Henan Taloph Pharmaceutical Stock Co.,Ltd was founded in 1993 and is based in Zhengzhou, China.

Corporate Governance

TALOPH PHARM’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

December 9, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers